The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of neoadjuvant radiation therapy modalities on post-surgical lymphopenia in operable pancreatic cancer.
 
Soon Khai Low
No Relationships to Disclose
 
Samih Thalji
No Relationships to Disclose
 
Mohammed Aldakkak
No Relationships to Disclose
 
Grace Ying
No Relationships to Disclose
 
Stephanie Yohay
No Relationships to Disclose
 
Elizabeth Auckley
No Relationships to Disclose
 
Parnian Vakili
No Relationships to Disclose
 
Faisal Shahjehan
No Relationships to Disclose
 
Douglas Evans
No Relationships to Disclose
 
Kathleen Christians
No Relationships to Disclose
 
Yongwoo Seo
No Relationships to Disclose
 
Beth Erickson
No Relationships to Disclose
 
Christina Small
Other Relationship - Society for Women in Radiation Oncology
 
Vaughn Heyer
No Relationships to Disclose
 
Bhabishya Neupane
No Relationships to Disclose
 
Ben George
Consulting or Advisory Role - AstraZeneca; Boston Scientific; Bristol-Myers Squibb; Foundation Medicine; Ipsen; Roche/Genentech; Taiho Pharmaceutical; Tempus
Speakers' Bureau - AstraZeneca; Taiho Oncology
Research Funding - CARsgen Therapeutics (Inst); GlycoNex (Inst); Helix BioPharma (Inst); Helix BioPharma (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Sirnaomics (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transcenta (Inst); Trishula Therapeutics (Inst); Tvardi Therapeutics (Inst)
 
Anai Kothari
No Relationships to Disclose
 
William Hall
Stock and Other Ownership Interests - Sonoptima
Consulting or Advisory Role - Aktis Oncology; Sonoptima
Research Funding - Elekta (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for a wearable device for radiation treatment planning (Inst)
Travel, Accommodations, Expenses - Elekta (Inst)
 
Mandana Kamgar
Research Funding - Cornerstone Pharmaceuticals (Inst); OneCell Diagnostics India (Inst)